Papain-like cysteine proteases are important for the survival of the flagellated protozoa Trypanosoma cruzi, the causative agent of Chagas' Disease. The lysosomal cysteine protease designated as cruzipain or cruzain, is the archetype of a multigene family of related isoforms. We investigated the substrate specificity of the cruzipain 2 isoform using internally quenched fluorogenic substrates. We found that cruzipain 2 and cruzain differ substantially regarding the specificity in the S 2 , S 0 1 and S 0 2 pockets. Our study indicates that cruzipain 2 has a more restricted specificity than cruzain, suggesting that these isoforms might act on distinct natural substrates.
Introduction
Cysteine proteases are regarded as essential for the survival of several parasitic protozoa (reviewed in Sajid & McKerrow, 2002) . In Trypanosoma cruzi, the etiological agent of Chagas' Disease, the major cysteine protease, cruzipain, has been the subject of extensive biochemical and structural studies in the past decade (reviewed in Cazzulo et al., 1997) . Studies using synthetic irreversible cysteine protease inhibitors in vitro and in vivo validated cruzipain as a potential chemotherapeutical target (Meirelles et al., 1992; Harth et al., 1993; Engel et al., 1998) . Cruzipain is a papain-like proteinase, which shares biochemical characteristics with both cathepsin L and cathepsin B (Cazzulo et al., 1990a; Murta et al., 1990; Lima et al., 1992) . As other papain-like enzymes, it is synthesized as a proenzyme that undergoes maturation by proteolytic excision of the N-terminal prodomain. However, unlike its mammalian counterparts, cruzipain has an unusual highly glycosylated 130 amino acids carboxy-terminal extension, with unknown function, which is not required for proteolytic activity (Aslund et al., 1990; Eakin et al., 1992) .
Although cruzipain was operationally defined as the major cysteine proteinase detected in T. cruzi epimastigotes (the noninfective stage found in the insect vector), this protease is a member of a large multigene family composed of polymorphic genes (Campetella et al., 1992; Lima et al., 1994) , whose expression are stage regulated in the parasite (Tomas & Kelly, 1996) . Studies using reverse transcriptase PCR (RT-PCR) showed that in epimastigotes the majority of cruzipain RNA encodes highly similar isoforms (4 95% amino acid identity), while in trypomastigotes and amastigotes, the mammalian stages of the parasite, the expression of more divergent cruzipain genes can be detected (Lima et al., 1994) . The majority of the biochemical studies on cruzipain were performed using the natural enzyme purified from epimastigotes (Cazzulo et al., 1990b; Parodi et al., 1995; Cazzulo et al., 1996; Serveau et al., 1996; Nery et al., 1997; Meldal et al., 1998; Serveau et al., 1999) . For simplicity, we refer to the major isoform isolated from epimastigotes as cruzipain 1 (n-cruzipain 1). A representative member of the cruzipain-1 complex was expressed in Escherichia coli truncated at the C-terminus and the recombinant enzyme was named cruzain (r-cruzain) (Eakin et al., 1992) . The resolution of r-cruzain's X-ray structure revealed details about structure-function, leading to the design of specific inhibitors with potent trypanocidal activity (McGrath et al., 1995; Gillmor et al., 1997) . Structural studies showed that the active site region of r-cruzain is very similar to that of other papain-like members, extending over seven substrate-binding sites, four of which (S 4 -S 1 ) are located on the acyl side of the cleaved bond and three (S 0 1 À S 0 3 ) on the amino side (McGrath et al., 1995; Gillmor et al., 1997) . Previous studies defined the contribution of the substrate residues interacting with each of the subsites to the specificity of n-cruzipain 1 purified from epimastigotes (Nery et al., 1997) . Subsequently, a systematic study regarding the specificity of r-cruzain was reported (Judice et al., 2001) .
Although the kinetic properties of n-cruzipain 1 were studied in detail, little is known about the functional properties of the divergent isoforms. The characterization of one of these isoforms, cruzipain 2 (r-cruzipain 2), expressed truncated at the carboxy terminus in Saccharomyces cerevisiae, revealed an enzyme presenting substrate preference and susceptibility to inactivation by inhibitors distinct from those of r-cruzain . Cruzipain 2 is preferentially expressed by trypomastigotes and amastigotes, the mammalian stages of the parasite. Given the potential functional diversity between cruzipain isoforms, it becomes important for drug-design strategies the characterization of the biochemical and kinetic properties of these enzymes. In this work, we refined the analysis of the substrate specificity of r-cruzipain 2 using internally quenched fluorescent peptides with ortho-amino benzoic acid (Abz) and N-[2,4-dinitrophenyl]-ethylenediamine (EDDnp) fluorescence donor and receptor groups, respectively. We showed that r-cruzipain 2 diverges from r-cruzain regarding specificity requirements in the S 2 , S 0 1 and S 0 2 subsites, and discussed the implications of these findings.
Materials and methods

Recombinant enzyme and substrates
Recombinant cruzipain 2 was expressed and purified as described previously . Cruzain was a gift from J. McKerrow (UCSF, San Francisco). The intramolecularly quenched fluorogenic substrates were synthesized by solid phase synthesis as described previously (Meldal et al., 1998) . Briefly: N a -fluoren-a-ylmethoxycarbonyl-Glu(aCO)-N-EDDnp was attached to benzhydrylamino resin through as p-{(R,S)-a-[1-(9H-fluoren-9-yl)methoxyformamido]-2, 4-dimethoxybenzylphenoxyacetic acid} linker and the peptides were synthesized by fluoren-a-ylmethoxycarbonyl methodology using a multiple automated peptide synthesizer PSSM-8 (Shimadzu). Each substrate was diluted at 1 mg mL À1 in dimethyl sulfoxide (DMSO) and the molar concentration was determined as follows: substrates were diluted 50 times in reaction buffer and the optical density at 365 nm was measured in a spectrophotometer, the concentration was determined using e = 17 300 M À1 cm À1 .
Kinetics
The hydrolysis of the substrates were monitored in continuous assays by measuring the fluorescence at 320 nm excitation and 420 nm emission in a F4500 (Hitachi) fluorimeter, in 50 mM Na 2 HPO 4 , 100 mM NaCl, 5 mM EDTA, pH 6.5, 5% DMSO, 5 mM dithiothreitol, at 30 1C, using a Hitachi F-4500. To ensure stability, the enzymes were kept on ice until assayed. The initial velocities were calculated by linear regression of the substrate hydrolysis curves. The enzyme concentration was determined by active site titration using recombinant human cystatin C (a gift from M. Abrahamson). The titration was performed upon incubation of the enzymes with various inhibitor concentrations at room temperature for 1 h. The remaining activity was measured upon addition of e-NH 2 (Cap)-L-(SBzl)C-AMC (Nery et al., 1997) at a final concentration of 10 mM. The kinetic parameters K m and k cat were determined using the Michaelis and Menten equation on Graffit 3.0 for Windows to fit
curves. The kinetics were performed at least three independent times with each substrate.
Results and discussion
Influence of the P 3 , P 2 and P 1 residues in the substrate specificity of cruzipain 2
We used seven residues intramolecularly quenched fluorogenic Abz-peptidyl-EDDnp substrates containing systematic substitutions in either side of the scissile bond to evaluate the contribution of these positions in the kinetic parameters of recombinant cruzipain 2 (r-cruzipain 2) ( Table 1 ). In contrast with di-or tri-peptidyl-MCA substrates, the use of longer substrates, which span the entire active site of papainlike proteases, allows a more accurate determination of the specificity restrains of this isoform. This series of substrates was previously used in the investigation of the substrate specificity of r-cruzain (Judice et al., 2001) , allowing the comparison of the kinetic properties of these isoforms. We found that the activity (k cat /K m ) of r-cruzipain 2 was consistently lower as compared with r-cruzain, mainly due to K m values five to 20 times higher than those of r-cruzain (Judice et al., 2001) . The scan of substrates with substitutions in the P 1 position revealed that r-cruzipain 2 presents a marked preference for positively charged residues in this position, showing a slight (twofold) preference for Arg over Lys. Consistent with previous results using peptidyl-MCA substrates, r-cruzipain 2 also presented distinctively higher activity towards the substrate containing (SBz)Cys in P 1 , discriminating it from substrates containing Phe or Gly at this position. Although the preference for positive residues in P 1 is shared with r-cruzain, the latter does not discriminate (SBz)Cys from Phe or Gly in P 1 (Judice et al., 2001) . The evaluation of the S 2 subsite specificity showed that, differently from n-cruzipain 1 or r-cruzain, r-cruzipain 2 selects for Leu in the P 2 position, displaying a marked preference (10-fold) for Leu over Phe in P 2 . The previous characterization of r-cruzain with the same substrate series showed that Phe and Leu are accepted in P 2 , with a slight preference (twofold) for Leu over Phe . This result suggests that the S 2 pocket of r-cruzipain 2 might be more restricted than that of r-cruzain, as the latter accepts equally well bulky and small hydrophobic or basic residues in P 2 (Nery et al., 1997; Judice et al., 2001) . This is in agreement with previous results showing that the hydrolysis of Z-Phe-Arg-MCA by r-cruzipain 2 was rather inefficient . Structural studies of r-cruzain in complex with irreversible inhibitors showed that residues Leu67, Ala133 and Leu157 lined with the S 2 pocket readily accommodate the Phe residue at P 2 , which interacts with the enzyme's backbone via the carbonyl of Gly66 (Brinen et al., 2000) . We might speculate that the Ser133 substitution found in cruzipain 2, combined with the proximal change of Met68 to Ser68 in cruzipain 2, may ultimately influence the enzyme's S 2 specificity. Studies of molecular modeling suggest that this subsite is narrower in cruzipain 2 as compared with cruzain (L. Dardenne and P. Bisch, unpublished data), possibly justifying the poor accommodation of Phe in the S 2 pocket of r-cruzipain 2. Interestingly, the marked preference for Leu over Phe in P 2 is a feature observed with mammalian cathepsins S and K, but not with cathepsins L, F or B (Wang et al., 1998) . Although cathepsins L, S and F can be concomitantly expressed in the same cell type, studies with knock-out mice revealed that these enzymes do not play redundant roles (Nagler & Ménard, 2003) . R-cruzipain 2 was also able to hydrolyze a substrate containing a positively charged residue in P 2 (Arg), a feature of cathepsin B. This functional property was previously demonstrated in studies with either n-cruzipain 1 or rcruzain (Lima et al., 1992; Nery et al., 1997; Judice et al., 2001) , being attributed to the presence of a Glu residue at the bottom of the S 2 pocket, which interacts with the positive charge, stabilizing basic residues in the pocket (Gillmor et al., 1997) . Indeed, a Glu residue is also present at position 208 (cruzain numbering) of the cruzipain 2 sequence (Lima et al., 1994) . When Pro was present in P 2 , the efficiency of hydrolysis of the substrate was 100-fold lower than that observed when Leu was in P 2 , both due to low affinity and low K cat values. This is in contrast with the results obtained with r-cruzain, which tolerates Pro in P 2 showing only a 10-fold reduction in the K cat /K m , as compared with the substrate containing Leu in P 2 (Judice et al., 2001) . As the S 2 subsite is considered the only well-defined and true specificity pocket of papain-like proteases (Turk et al., 1998) , differences in S 2 specificity suggest that these isoforms might be tailored to process distinct natural substrates or the same substrate at alternative cleavage sites. When the residues in P 3 were varied, we did not observe any significant change in enzyme activity, which is in agreement with the notion that the residues in this position make only superficial contact with papain-like enzymes and are not likely to have an influence in the enzyme specificity.
Influence of the P 1 0 , P 2 0 and P 3 0 residues in the substrate specificity of cruzipain 2 R-cruzipain 2 also displayed a more restricted specificity than n-cruzipain 1 or r-cruzain when we evaluated substitutions at the P 0 1 position. While n-cruzipain 1 and r-cruzain accept equally hydrophobic residues (Leu, Phe and Ala) or basic residues (Arg) in P 0 1 , r-cruzipain 2 displayed a 20-fold preference for Leu or Phe over Arg. In addition, r-cruzipain 2 also showed a fivefold reduction in the efficiency of hydrolysis when Ala was in this position, indicating that the enzyme markedly selects for hydrophobic residues in P 0 1 . A study of the structural determinants of the S 0 1 specificity of r-cruzain in complex with inhibitors revealed that extensive hydrogen bonding and electrostatic interactions in this area rather than aromatic interactions are important for specificity (Brinen et al., 2000) . Noteworthy, interactions of the residue in P 0 1 of the inhibitor with Asp158 were observed, and the substitution of this residue by Ser158 in cruzipain 2 might constrain the accommodation of Arg in the S 0 1 of r-cruzipain 2.
R-cruzipain 2 accommodated Ser, Phe or Ala equally in P 0 2 but the substrate containing Pro was hydrolyzed poorly, mostly due to lower K cat values. This is in contrast with previous characterization of r-cruzain, which hydrolyzed with similar efficiency the above-mentioned substrates, independently of the nature of the residue present in P 0 2 (Judice et al., 2001) . The efficient cleavage of a substrate with Pro at P 0 2 by r-cruzain may have biological implications because of the nature of the cleavage site (VVG # APA) involved in the autocatalytic processing of zymogens. Of note, this cleavage site is shared by both isoforms. We may anticipate that cruzipain 2 zymogens may not undergo efficient self-maturation, thus depending on cruzipain 1 for trans-activation. If true, the in vivo effects of inhibitors designed against cruzipain 1 may be enhanced due to impaired procruzipain 2 trans-activation by cruzipain 1.
As expected, substitutions in the P 0 3 position did not significantly affect substrate hydrolysis by r-cruzipain 2, and we found similar results when investigated the influence of P 0 3 in the specificity of r-cruzain (not shown). Surprisingly, and in contrast to the observed with r-cruzain, we were unable to detect hydrolysis of the substrate containing Phe at P 0 3 by r-cruzipain 2. This observation suggests that the residue in this position possibly makes important contacts with the enzyme surface, a property that may be explored in the design of inhibitors partially selective to r-cruzain over rcruzipain 2.
We have reported that r-cruzipain 2 is mainly expressed by amastigotes and trypomastigotes . It is of note that both n-cruzipain 1 and n-cruzipain 2 may participate cooperatively in relevant biological processes such as host cell signaling and invasion by T. cruzi (Scharfstein et al., 2000; Aparicio et al., 2004) . Additional studies are required to clarify if T. cruzi is able to exploit the repertoire of functionally diverse cruzipain isoforms to invade a broad range of host cells (Scharfstein, 2003) . The combined differences in specificity observed in r-cruzipain 2, as compared with r-cruzain, could be exploited in the design of partially selective inhibitors, aiming at the study of independent contribution of theses activities to the physiology of Trypanosoma cruzi.
